Polypharmacy - A new challenge in an aging society;Polypharmazie - Eine neue Herausforderung in einer alternden Gesellschaft

Wiener Medizinische Wochenschrift

Volumn 160, Issue 11-12, 2010, Pages 261-263

  Gosch, Markus ^a   Roller, Regina E ^b  

^a Hospital Hochzirl   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; NON PRESCRIPTION DRUG;

DRUG ELIMINATION; DRUG INTERACTION; DRUG METABOLISM; EDITORIAL; GERIATRIC DISORDER; HUMAN; PATIENT COMPLIANCE; POLYPHARMACY; PRACTICE GUIDELINE;

EID: 77957296584     PISSN: 00435341     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10354-010-0783-4     Document Type: Editorial

References (16)

1. http://www.statistik.at/web-de/statistiken/bevoelkerung/ bevoelkerungsstruktur/bevoelkerung-nach-alter-geschlecht/index.html
2. http://www.who.int/ageing/en/
3. AA Uijen EH van de Lisdonk 2008 Multimorbidity in primary care: prevalence and trend over the last 20 years Eur J Gen Pract 14 Suppl 1 28 32 10.1080/13814780802436093 18949641
4. Gosch M. Polypharmazie: Pharmakotherapie mit Qualität MMA Geriatrie Praxis 01/2008
5. J Lazarou BH Pomeranz PN Corey 1998 Incidence of adverse drug reactions in hospitalized patients - a metaanalysis of prospective studies JAMA 279 1200 1205 10.1001/jama.279.15.1200 1:STN:280:DyaK1c3hsFSnsQ%3D%3D 9555760 (Pubitemid 28193431)
6. J Ebbesen I Buajordet J Erikssen O Brørs T Hilberg H Svaar L Sandvik 2001 Drug-related deaths in department of internal medicine Arch Intern Med 161 2317 2323 10.1001/archinte.161.19.2317 1:STN:280:DC%2BD3Mnks1yhtg%3D%3D 11606147
7. JU Schnurrer JC Frölich 2003 Incidence and prevention of lethal undesirable drug effects Internist (Berl) 44 889 895 10.1007/s00108-003-0988-3 1:STN:280:DC%2BD3srlt1OmtQ%3D%3D (Pubitemid 36890019)
8. JT Hanlon KE Schmader KJ Koronkowski, et al. 1997 Adverse drug events in high risk older outpatients J Am Geriatr Soc 45 945 948 1:STN:280: DyaK2svgtV2ruw%3D%3D 9256846
9. CA Colley LM Lucas 1993 Polypharmacy: the cure becomes the disease J Gen Intern Med 8 278 283 10.1007/BF02600099 1:STN:280:DyaK3s3otVKlsg%3D%3D 8505690
10. M Chester L Chen JC Kaski 1995 Identification of patients at high risk for adverse coronary events while waiting routine coronary angioplasty Br Heart J 73 216 222 10.1136/hrt.73.3.216 1:STN:280:DyaK2M3ksVWqtQ%3D%3D 7727179
11. DM Fick JW Cooper WE Wade, et al. 2003 Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts Arch Intern Med 161 2712 2716
12. Côté I, Farris K, Olson K, et al. Assessing the usefulness of the medication appropriateness index in a community setting. working paper 03.01; 2003. http://www.ihe.ca/documents/2003-01paper.pdf
13. Yazid K, Aichhorn W. Wilde Mischung mit ungewissen Folgen, Polypharmazie im höheren Lebensalter. Ärzte Woche 22/6, 2008
14. RN Greenberg 1984 Overview of patient compliance with medication dosing: a literature review Clin Ther 6 592 599 1:STN:280:DyaL2M%2FgtF2htA%3D%3D 6383611
15. MA Kuijpers RJ van Marum AC Egberts PA Jansen 2007 Relationship between polypharmacy and underprescribing Br J Clin Pharmacol 65 130 133 10.1111/j.1365-2125.2007.02961.x 17578478
16. P Gallagher C Ryan S Byrne J Kennedy D O'Mahoney 2008 STOPP (Screening tool of older person's prescriptions) and START (Screening tool to alert doctors to right treatment). Consensus validation Int J Clin Pharm Thera 66 72 83